Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Int J Mol Sci ; 23(2)2022 Jan 17.
Article in English | MEDLINE | ID: covidwho-1624942

ABSTRACT

Tuberculosis (TB) infection, caused by the airborne pathogen Mycobacterium tuberculosis (M.tb), resulted in almost 1.4 million deaths in 2019, and the number of deaths is predicted to increase by 20% over the next 5 years due to the COVID-19 pandemic. Upon reaching the alveolar space, M.tb comes into close contact with the lung mucosa before and after its encounter with host alveolar compartment cells. Our previous studies show that homeostatic, innate soluble components of the alveolar lining fluid (ALF) can quickly alter the cell envelope surface of M.tb upon contact, defining subsequent M.tb-host cell interactions and infection outcomes in vitro and in vivo. We also demonstrated that ALF from 60+ year old elders (E-ALF) vs. healthy 18- to 45-year-old adults (A-ALF) is dysfunctional, with loss of homeostatic capacity and impaired innate soluble responses linked to high local oxidative stress. In this study, a targeted transcriptional assay shows that M.tb exposure to human ALF alters the expression of its cell envelope genes. Specifically, our results indicate that A-ALF-exposed M.tb upregulates cell envelope genes associated with lipid, carbohydrate, and amino acid metabolism, as well as genes associated with redox homeostasis and transcriptional regulators. Conversely, M.tb exposure to E-ALF shows a lesser transcriptional response, with most of the M.tb genes unchanged or downregulated. Overall, this study indicates that M.tb responds and adapts to the lung alveolar environment upon contact, and that the host ALF status, determined by factors such as age, might play an important role in determining infection outcome.


Subject(s)
Bacterial Capsules/genetics , Bacterial Capsules/metabolism , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/metabolism , Adolescent , Adult , Age Factors , Aged , Bronchoalveolar Lavage Fluid , Cellular Structures , Female , Gene Expression Regulation, Bacterial , Humans , Lipopolysaccharides/biosynthesis , Lipopolysaccharides/genetics , Male , Mannosides/biosynthesis , Mannosides/genetics , Mannosyltransferases/biosynthesis , Mannosyltransferases/genetics , Middle Aged , Young Adult
2.
Eur J Med Genet ; 64(10): 104268, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1401450

ABSTRACT

Pathogenic variants in phosphatidylinositol glycan anchor biosynthesis class B (PIGB) gene have been first described as the cause of early infantile epileptic encephalopathy 80 (EIEE-80) in 2019. This disorder, an inherited glycosylphosphatidylinositol deficiency, is associated with a complex neurologic phenotype, including developmental delay, early-onset epilepsy and peripheral neuropathy. We report on a 5 year-old girl born from consanguineous parents, manifesting severe global developmental delay with absent speech, mixed peripheral polyneuropathy, hypotonia, bilateral equino-varo-supinated-cavus foot, early-onset scoliosis, elevated serum alkaline phosphatase and a single episode of febrile status epilepticus. Hypomyelination was documented on brain MRI. Whole-exome sequencing (WES) disclosed the likely pathogenic biallelic PIGB NM_004855.4: c.463G > C, p.(Asp155His) missense variant. In our patient, while other characteristic clinical, neuroimaging and laboratory findings (as described in the first research paper) were present, seizures were not a major clinical issue, thus contributing to our knowledge on this ultra-rare disorder.


Subject(s)
Brain/physiopathology , Developmental Disabilities/genetics , Epilepsy/genetics , Mannosyltransferases/genetics , Peripheral Nervous System Diseases/genetics , Brain/diagnostic imaging , Child , Developmental Disabilities/diagnosis , Electroencephalography , Epilepsy/diagnosis , Female , Humans , Mannosyltransferases/deficiency , Peripheral Nervous System Diseases/diagnosis , Exome Sequencing
SELECTION OF CITATIONS
SEARCH DETAIL